Dairy Farmers of Canada eager to work with new government

Oct 22, 2019

OTTAWA - Dairy Farmers of Canada (DFC) congratulates Prime Minister Justin Trudeau and the Liberal party on winning the 2019 federal election, and forming a minority government. DFC also extends its congratulations to Mr. Scheer and the Conservative party for forming the official opposition, and to all opposition leaders for a hard-fought campaign.

In the context of a minority government, support from all parties for dairy issues becomes essential. Throughout the campaign, all parties with MP's elected to the House of Commons today have taken positions in support of dairy farmers, and we thank them for their commitments.

During the campaign, the parties pledged to compensate dairy farmers for trade agreement-related losses, and committed to no more concessions in future trade agreements, as well as being favourable to keeping the current Canadian content threshold to ensure transparency for the "Product of Canada" label.

"We will continue to work collaboratively with Prime Minister Trudeau's new government as well as with all opposition parties, on behalf of dairy farmers from across the country, to ensure a thriving dairy sector today and for future generations of dairy farmers," added Mr. Lampron.

Source : CISION

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.